Literature DB >> 11568363

Assessment of cisplatin-induced nephrotoxicity by microarray technology.

Q Huang1, R T Dunn, S Jayadev, O DiSorbo, F D Pack, S B Farr, R E Stoll, K T Blanchard.   

Abstract

Microarrays are a new technology used to study global gene expression and to decipher biological pathways. In the current study, microarrays were used to examine gene expression patterns associated with cisplatin-mediated nephrotoxicity. Sprague-Dawley rats received either single or seven daily ip doses of cisplatin (0.5 or 1 mg/kg/day) or the inactive isomer transplatin (1 or 3 mg/kg/day). Histopathological evaluation revealed renal proximal tubular necrosis in animals that received cisplatin for 7 days, but no hepatotoxic findings. Microarray analyses were performed using rat specific arrays containing 250 toxicity-related genes. Prominent gene expression changes were observed only in the kidneys of rats that received cisplatin for 7 days. Mechanistically, the gene expression pattern elicited by cisplatin (e.g., Bax upward arrow and SMP-30 downward arrow) suggested the occurrence of apoptosis and the perturbation of intracellular calcium homeostasis. The induction of multidrug resistance genes (MDR1 upward arrow, P-gp upward arrow) and tissue remodeling proteins (clusterin upward arrow, IGFBP-1 upward arrow, and TIMP-1 upward arrow) indicated the development of cisplatin resistance and tissue regeneration. Select gene expression changes were further confirmed by TaqMan analyses. Gene expression changes were not observed in the liver following cisplatin administration. In contrast to these in vivo findings, studies using NRK-52E kidney epithelial cells and clone-9 liver cells suggested that liver cells were more sensitive to cisplatin treatment. The discrepancies between the in vivo and in vitro results suggest that caution should be taken when extrapolating data from in vivo to in vitro systems. Nonetheless, the current study elucidates the biochemical pathways involved in cisplatin toxicity and demonstrates the utility of microarrays in toxicological studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568363     DOI: 10.1093/toxsci/63.2.196

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  39 in total

Review 1.  The evolution of bioinformatics in toxicology: advancing toxicogenomics.

Authors:  Cynthia A Afshari; Hisham K Hamadeh; Pierre R Bushel
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

2.  Overexpression of p18INK⁴C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis.

Authors:  Yi Zhang; Li Yuan; Lili Fu; Chunyan Liu; Dongmei Liu; Changlin Mei
Journal:  Pediatr Nephrol       Date:  2011-04-15       Impact factor: 3.714

Review 3.  Use of transcriptomics in understanding mechanisms of drug-induced toxicity.

Authors:  Yuxia Cui; Richard S Paules
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

4.  Protection of cisplatin cytotoxicity by an inactive cyclin-dependent kinase.

Authors:  Rawad Hodeify; Judit Megyesi; Adel Tarcsafalvi; Robert L Safirstein; Peter M Price
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-05

5.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

6.  Piceatannol protects against cisplatin nephrotoxicity via activation of Nrf2/HO-1 pathway and hindering NF-κB inflammatory cascade.

Authors:  Sara A Wahdan; Samar S Azab; Doaa A Elsherbiny; Ebtehal El-Demerdash
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-14       Impact factor: 3.000

7.  Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses.

Authors:  Peter S T Yuen; Sang-Kyung Jo; Mikaela K Holly; Xuzhen Hu; Robert A Star
Journal:  Physiol Genomics       Date:  2006-02-28       Impact factor: 3.107

8.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

Authors:  Ganesan Ramesh; W Brian Reeves
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway.

Authors:  Yingmei Liu; Xiaodan Lu; Sinh Nguyen; Jean L Olson; Heather K Webb; Deanna L Kroetz
Journal:  Mol Pharmacol       Date:  2013-10-03       Impact factor: 4.436

10.  Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.

Authors:  Alan R Parrish; Gang Chen; Robert C Burghardt; Takaho Watanabe; Christophe Morisseau; Bruce D Hammock
Journal:  Cell Biol Toxicol       Date:  2008-04-03       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.